Adult Cystic Fybrosis

Chair(s): Mirjam Stahl, Clemence Martin

Session type: Symposium

Stephanie Thee

Session content


Nicholas Simmonds

Replay

Slides


Changing profile of infection and microbiome in CF: When to use antibiotics in the era of HEMT

Stephanie Thee

Replay

Slides



Discussion and Q&A


After this session, the auditorium has gained insights into inflammation in CF lung disease starting soon after birth and the problems with treating this aspect of CF. Furthermore, the role of antimicrobial therapy, especially in the era of highly effective CFTR modulator therapy, will be discussed. In addition, lessons that can be learned from the treatment of the heterogenous group of people with non-CF bronchiectasis will be presented to stimulate transfer of knowledge to CF, where bronchiectasis is as a hallmark of lung disease.